| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/21/2004 | US20040209326 Immunoglobulin for use in detection and prevention staphylococcus infections |
| 10/21/2004 | US20040209323 Protein expression by codon harmonization and translational attenuation |
| 10/21/2004 | US20040209314 Comprises multimer of major histocompatibility complex which binds peptide-specific CD8+ T lymphocyte populations for use as diagnostic components of immunoassay; immunotherapy |
| 10/21/2004 | US20040209313 T2R receptor binding assays that identify potential bitter taste modulatory compounds |
| 10/21/2004 | US20040209310 Ligands that bind to the amyloid-beta precursor peptide and related molecules and uses thereof |
| 10/21/2004 | US20040209309 Compositions and methods for the specific detection of mammalian muscle proteins |
| 10/21/2004 | US20040209308 Methods of assaying receptor activity and constructs useful in such methods |
| 10/21/2004 | US20040209306 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 10/21/2004 | US20040209296 Using transcription factor inhibitors and human leukocyte antigen antibodies to prevent and treatcell proliferfative disorders; genetic vaccines and antitumor agents |
| 10/21/2004 | US20040209295 Chimeric MHC protein and oligomer thereof |
| 10/21/2004 | US20040209292 Mutant human hepatitis B viral strain and uses thereof |
| 10/21/2004 | US20040209289 BTL-II nucleic acids, proteins, and antibodies |
| 10/21/2004 | US20040209287 OCT1p, a protein having homology to the organic and sugar transporter family of proteins, and uses thereof |
| 10/21/2004 | US20040209286 Comprises nucleotide sequences coding g protein coupled receptors for use in identifying modulators of sweet taste transduction; food processing; improving palatability of low-calorie beverages through the development of new artificial sweeteners |
| 10/21/2004 | US20040209285 Nucleotide sequences which code for the ccpa2 gene |
| 10/21/2004 | US20040209284 Nucleotide sequences coding receptor proteins for use in identifying modulators for treatment of autoimmune diseases |
| 10/21/2004 | US20040209279 Comprises regulatory nucleotide sequences for generating animal model for liver disorders |
| 10/21/2004 | US20040209275 Using biomarker expression to detect and screen for degenerative bone diseases |
| 10/21/2004 | US20040209273 Plant stress-regulated genes |
| 10/21/2004 | US20040209265 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins and uses thereof |
| 10/21/2004 | US20040209264 Comprises nucleotide sequences coding daugther of legless protein for use in identifying modulator for tissue regeneration and repair and the treatment of blood disorders |
| 10/21/2004 | US20040209250 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 10/21/2004 | US20040209248 Comprises modified viral surface protein for use in detection and diagnosis of hepatitis infection |
| 10/21/2004 | US20040209241 plasmids encoding amino acid sequences containing HCMV glycoprotein B polypeptide; immunotherapy; viricides; site-directed mutagenesis |
| 10/21/2004 | US20040209239 Methods and compositions fir identifying episomal dna virus infection treatment |
| 10/21/2004 | US20040208978 Pediococcus pentosaceus YJL with the accession numbers FERM-BP 8450 (BCRC 910210); inoculation; controlling fermentation; reduced growth of unwanted microorganisms, improved flavor, texture, color and enhanced economic value; storage stability |
| 10/21/2004 | US20040208907 using toxin complex (TC) proteins obtainable from Xenorhabdus, Photorhabdus, and Paenibacillus to control insects; transgenic plant or plant cell with the proteins |
| 10/21/2004 | US20040208900 mutant rabies virus comprising a rabies virus N protein that is not phosphorylated; central nervous system (CNS) |
| 10/21/2004 | US20040208890 secreted Chlamydia polypeptides expressed by a Gram-negative bacterial strain and secreted by the type III secretion pathway; vaccination, and diagnostic uses |
| 10/21/2004 | US20040208889 Pharmaceutical use for secreted bacterial effector proteins |
| 10/21/2004 | US20040208888 Method of and compositions for immunization with the pseudomonas v antigen |
| 10/21/2004 | US20040208886 DNA sequences encoding the proteins; drugs with the proteins or the DNA; for the preparation of antigens for treating tumoral diseases; administering |
| 10/21/2004 | US20040208884 Administering construct in conjugated or unconjugated form and in combination with immunogenic carrier to induce antibodies; anticarcinogenic agents |
| 10/21/2004 | US20040208881 B1k chain of laminin and methods of use |
| 10/21/2004 | US20040208880 Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells |
| 10/21/2004 | US20040208879 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 10/21/2004 | US20040208878 Treatment of acute lung injury, fibrosis and metastasis with antagonists of alphabetav6 |
| 10/21/2004 | US20040208872 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 10/21/2004 | US20040208867 Mutant protein with amino acid sequence that is substituted, deleted, inserted or transposed; 3'-phosphoadenosine5'-phosphosulfate; gene expression; medical diagnosis |
| 10/21/2004 | US20040208866 Methods of regulating body weight |
| 10/21/2004 | US20040208863 Anti-inflammatory activity from lactic acid bacteria |
| 10/21/2004 | US20040208857 Producing a donor-specific immunotolerance against transplanted tissue by administering embryonic stem cell-like cell lines (ECL) obtained from blastocysts and are transfected with genetic material of the donor, which codes for the major histocompatibility complex (MHC) haplotypes |
| 10/21/2004 | US20040208851 Immunization by inoculation of DNA transcription unit |
| 10/21/2004 | US20040208850 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 10/21/2004 | US20040208849 Reducing viability of tumor cell by administering virus that is not a common human pathogen such as a Rhabdovirus, a picomavirus, and preferably is vesicular stomatitis virus (VSV) |
| 10/21/2004 | US20040208846 Mini-Ad vector for immunization |
| 10/21/2004 | US20040208824 Covalent bonded to a chelator 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid, and labeled with a metal ion of a radionuclide; use as drugs and diagnostic purpose; lymphoma, leukemia, myeloma, lupus erythrematosus, rheumatoid arthritis, multiple sclerosis, Crohn's disease, diabetes, asthma |
| 10/21/2004 | US20040208786 Autologous coagulant produced from anticoagulated whole blood |
| 10/21/2004 | CA2563393A1 Ml - iap peptides induce anti-melanoma cytotoxic t-cell response |
| 10/21/2004 | CA2523186A1 Method of screening drug with the use of 67 kda laminin receptor and drug obtained thereby |
| 10/21/2004 | CA2521931A1 Use of hcv proteins |
| 10/21/2004 | CA2521856A1 Severe acute respiratory syndrome (sars) causing coronavirus |
| 10/21/2004 | CA2521469A1 Identification of novel nogo-receptors and methods related thereto |
| 10/21/2004 | CA2521438A1 Prion protein binding materials and methods of use |
| 10/21/2004 | CA2521273A1 Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production |
| 10/21/2004 | CA2520987A1 Targets for tumor growth inhibition |
| 10/21/2004 | CA2520875A1 Methods for rational pegylation of proteins |
| 10/21/2004 | CA2501222A1 Antibody recognizing antigen |
| 10/20/2004 | EP1469316A1 Screening method |
| 10/20/2004 | EP1469310A1 Diagnostic for scleroderma |
| 10/20/2004 | EP1469076A2 Recombinant PRRS proteins, diagnostic kits and vaccines containing said recombinant proteins |
| 10/20/2004 | EP1469075A1 Gene-therapy for solid tumors, papillomas and warts |
| 10/20/2004 | EP1469074A1 Human calcium channel compositions and methods |
| 10/20/2004 | EP1469073A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 10/20/2004 | EP1469072A2 Means and methods for diagnosing and treating affective disorders |
| 10/20/2004 | EP1469064A1 Expression of proteins in endothelial cells derived from precursor cells from cord blood |
| 10/20/2004 | EP1469011A1 Hemoglobin conjugates |
| 10/20/2004 | EP1469010A1 Transcription regulatory gene and peptide |
| 10/20/2004 | EP1468695A1 Methods and compositions useful for inhibition of angiogenesis |
| 10/20/2004 | EP1468293A1 Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases |
| 10/20/2004 | EP1468292A1 Diagnostic methods |
| 10/20/2004 | EP1468284A2 Method for measuring intracellular atp and/or gene expression |
| 10/20/2004 | EP1468116A2 Method for isolating nucleic acids and protein from a single sample |
| 10/20/2004 | EP1468100A2 Gb virus b based replicons and replicon enhanced cells |
| 10/20/2004 | EP1468091A2 Transmembrane protein |
| 10/20/2004 | EP1468087A2 Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1 |
| 10/20/2004 | EP1468081A1 Tyrosine kinase inhibitors |
| 10/20/2004 | EP1468080A1 INFECTIOUS cDNA CLONES OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND EXPRESSION VECTORS THEREOF |
| 10/20/2004 | EP1468079A1 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same |
| 10/20/2004 | EP1468076A1 Defective entities and uses therefor |
| 10/20/2004 | EP1468023A2 Binding proteins as biosensors |
| 10/20/2004 | EP1468022A1 Novel monoclonal antibody and nematode larval antigens |
| 10/20/2004 | EP1468021A2 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of chronic obstructive pulmonary disease |
| 10/20/2004 | EP1468020A2 Multimers of receptor-binding ligands |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1468017A1 A complex of a human foxc2 protein and a foxc2-interacting protein |
| 10/20/2004 | EP1468016A2 Genetic polymorphisms predicting cardiovascular disease and medication efficacy |
| 10/20/2004 | EP1468015A2 Novel compounds |
| 10/20/2004 | EP1468014A2 Compositions and methods for wt1 specific immunotherapy |
| 10/20/2004 | EP1468012A1 Biomolecule transduction motif mph-1-btm and the use thereof |
| 10/20/2004 | EP1468011A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 10/20/2004 | EP1467772A1 DIAGNOSTIC CONJUGATE USEFUL FOR INTRACELLULAR IMAGING AND FOR DIFFERENTIATING BETWEEN TUMOR− AND NON−TUMOR CELLS |
| 10/20/2004 | EP1467754A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 10/20/2004 | EP1467753A2 Recombinant herpesvirus of turkeys and use thereof |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467751A2 Immunogenic cea |
| 10/20/2004 | EP1467747A2 Use of dimer-specific nuclear localisation signal peptides (dsnls) derived from the stat dna binding domain |
| 10/20/2004 | EP1467746A2 Systems and methods for treating patients with collagen-rich material extracted from adipose tissue |
| 10/20/2004 | EP1467624A2 Methods of inducing or enhancing connective tissue repair |